A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer

PURPOSE: In head and neck and bladder cancer tumor hypoxia is associated with a poor prognosis, hypoxia modification improves outcome and hypoxic status predicts benefit from treatment. Yet, there is no universal measure of clinical hypoxia. The aim of this study was to investigate whether a 26-gene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Eustace, Amanda, Mani, Navin, Span, Paul N, Irlam, Joely J, Taylor, Janet, Betts, Guy NJ, Denley, Helen, Miller, Crispin J, Homer, Jarrod J, Rojas, Ana M, Hoskin, Peter J, Buffa, Francesca M, Harris, Adrian L, Kaanders, Johannes HAM, West, Catharine ML
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797516/
https://ncbi.nlm.nih.gov/pubmed/23820108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados